Rock Springs Capital LLC

10% owner at Verve Therapeutics, Inc. · on record since Jun 22, 2021
10% owner at Theseus Pharmaceuticals, Inc. · on record since Oct 14, 2021
10% owner at Q32 Bio Inc. · on record since Mar 27, 2018
10% owner at Inozyme Pharma, Inc. · on record since Jul 28, 2020
10% owner at Atea Pharmaceuticals, Inc. · on record since Oct 29, 2020
10% owner at Xilio Therapeutics, Inc. · on record since Oct 26, 2021
10% owner at Tempest Therapeutics, Inc. · on record since Jan 10, 2022
10% owner at Enliven Therapeutics, Inc. · on record since Mar 16, 2020

Insider trading activity of Rock Springs Capital LLC

Transactions on record: 12; since Mar 16, 2020

Open-market buys: 4; $17.6M

Open-market sells: 0

Companies traded: 3; last filing Oct 14, 2021

Figures computed from official regulatory filings — .

Companies where Rock Springs Capital LLC has traded

Theseus Pharmaceuticals, Inc.5 tx · $4M · Oct 14, 2021
Inozyme Pharma, Inc.4 tx · $9.6M · Jul 28, 2020
Enliven Therapeutics, Inc.3 tx · $4M · Mar 16, 2020

Track record of Rock Springs Capital LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Rock Springs Capital LLC

Co-insiders of Rock Springs Capital LLC

Rock Springs Capital Management LPAtea Pharmaceuticals, Inc. +5

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	OtherD (derivative)	-87,329	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Other	87,329	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	OtherD (derivative)	-349,320	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Buy	250,000	16.00 USD	$4M	conv 56ClusterFirst in 12mo	SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Other	349,320	—	n/a (No price was disclosed in the filing)		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 28, 2020	Other	467,884	—	n/a (No price was disclosed in the filing)		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 28, 2020	OtherD (derivative)	-3,496,504	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 28, 2020	Buy	24,000	16.00 USD	$384K	conv 40Cluster	SEC
Inozyme Pharma, Inc.Listing unverified	Jul 28, 2020	Buy	576,000	16.00 USD	$9.2M	conv 72Cluster	SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-1,722,222	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	273,411	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Buy	250,000	16.00 USD	$4M	conv 72ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	OtherD (derivative)	-87,329	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Other	87,329	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	OtherD (derivative)	-349,320	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Buy	250,000	16.00 USD	$4M	conv 56ClusterFirst in 12mo	SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Oct 14, 2021	Other	349,320	—	n/a (No price was disclosed in the filing)		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 28, 2020	Other	467,884	—	n/a (No price was disclosed in the filing)		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 28, 2020	OtherD (derivative)	-3,496,504	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Inozyme Pharma, Inc.Listing unverified	Jul 28, 2020	Buy	24,000	16.00 USD	$384K	conv 40Cluster	SEC
Inozyme Pharma, Inc.Listing unverified	Jul 28, 2020	Buy	576,000	16.00 USD	$9.2M	conv 72Cluster	SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-1,722,222	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	273,411	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Buy	250,000	16.00 USD	$4M	conv 72ClusterFirst in 12mo	SEC